Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, is providing insight into the company's enzymatic design capabilities and current areas of ...

SAN DIEGO, CA - April 16, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, is providing insight into the company’s enzymatic ...

Absci gained on animal testing phaseout news, but the change has limited near-term impact on its investment case. Read why ...

His expertise lies in transforming data into compelling visual narratives, offering unique insights into computational art and design. Art in Silico is a not-for-profit exhibition and event series; ...

A McKinsey report published in 2021 noted that carrying out CADD on quantum computers could increase the range of molecules amenable to in silico design, shorten screening times, and pick up ...

The study presents findings from in silico screening of billions of compounds ... was employed to design de novo molecules with optimized potency, selectivity, and BBB penetration.

Schrödinger’s stock surged after the FDA's initiative to phase out animal testing, benefiting its computational drug ...

hit-finding and degrader design, followed by automated chemistry synthesis and direct-to-biology screening and optimization, to rapidly generate degraders and degrader antibody conjugates (DACs ...

This screening was expanded for direct interacting pairs between piRNA-related proteins and proteins involved in oogenesis, as well as Piwi and other Drosophila proteins. This in silico approach not ...